Litigation Details for Manchester v. Purdue Pharma, L.P. (D. Vt. 2018)
✉ Email this page to a colleague
Manchester v. Purdue Pharma, L.P. (D. Vt. 2018)
| Docket | ⤷ Subscribe | Date Filed | 2018-04-20 |
| Court | District Court, D. Vermont | Date Terminated | 2022-11-29 |
| Cause | 31:3729 False Claims Act | Assigned To | William K. Sessions III |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,488,963; 8,114,383 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Manchester v. Purdue Pharma, L.P.
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe , ⤷ Subscribe , and ⤷ Subscribe .
Details for Manchester v. Purdue Pharma, L.P. (D. Vt. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-04-20 | 1 | license pertained to Patent no. 6,488,963 Bl (hereafter the "963 Patent") (Attachment 8). … On December 3, 2002 the U.S. Patent Office issued Patent no. 6,488,963 entitled 'HOT-MELT EXTRUDABLE…use the 963 PATENT earlier patented by University of Texas researchers in 2002. That PATENT pertained …In 1993 PURDUE filed a patent application for its product with the U.S. Patent Office. That application…granted on April 16, 1996 by patent no. 5,508,042 (hereafter "042 Patent") (Attachment 5) . The | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
